224 related articles for article (PubMed ID: 15708438)
21. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction.
Wang H; Durham L; Dawson H; Song P; Warner DS; Sullivan PM; Vitek MP; Laskowitz DT
Neuroscience; 2007 Feb; 144(4):1324-33. PubMed ID: 17187933
[TBL] [Abstract][Full Text] [Related]
22. Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology.
Wang C; Wilson WA; Moore SD; Mace BE; Maeda N; Schmechel DE; Sullivan PM
Neurobiol Dis; 2005 Mar; 18(2):390-8. PubMed ID: 15686968
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease.
Basso M; Gelernter J; Yang J; MacAvoy MG; Varma P; Bronen RA; van Dyck CH
Neurobiol Aging; 2006 Oct; 27(10):1416-24. PubMed ID: 16182410
[TBL] [Abstract][Full Text] [Related]
24. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.
Engelborghs S; Dermaut B; Mariën P; Symons A; Vloeberghs E; Maertens K; Somers N; Goeman J; Rademakers R; Van den Broeck M; Pickut B; Cruts M; Van Broeckhoven C; De Deyn PP
Neurobiol Aging; 2006 Feb; 27(2):285-92. PubMed ID: 16399213
[TBL] [Abstract][Full Text] [Related]
25. Role of apolipoprotein E in anxiety.
Raber J
Neural Plast; 2007; 2007():91236. PubMed ID: 17710250
[TBL] [Abstract][Full Text] [Related]
26. The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype.
Trembath D; Ervin JF; Broom L; Szymanski M; Welsh-Bohmer K; Pieper C; Hulette CM
Acta Neuropathol; 2007 Jan; 113(1):23-31. PubMed ID: 17089130
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade.
Ophir G; Amariglio N; Jacob-Hirsch J; Elkon R; Rechavi G; Michaelson DM
Neurobiol Dis; 2005 Dec; 20(3):709-18. PubMed ID: 15979312
[TBL] [Abstract][Full Text] [Related]
28. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
[TBL] [Abstract][Full Text] [Related]
29. Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice.
Sullivan PM; Mace BE; Maeda N; Schmechel DE
Neuroscience; 2004; 124(4):725-33. PubMed ID: 15026113
[TBL] [Abstract][Full Text] [Related]
30. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls.
Kramer G; van der Flier WM; de Langen C; Blankenstein MA; Scheltens P; Stam CJ
Clin Neurophysiol; 2008 Dec; 119(12):2727-32. PubMed ID: 18848805
[TBL] [Abstract][Full Text] [Related]
31. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
[TBL] [Abstract][Full Text] [Related]
32. Premorbid effects of APOE on synaptic proteins in human temporal neocortex.
Love S; Siew LK; Dawbarn D; Wilcock GK; Ben-Shlomo Y; Allen SJ
Neurobiol Aging; 2006 Jun; 27(6):797-803. PubMed ID: 15979210
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E and Alzheimer disease.
Huang Y
Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
[TBL] [Abstract][Full Text] [Related]
35. Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary.
Kovács KA; Pámer Z; Kovács A; Fekete S; Miseta A; Kovács B; Kovács GL
Ideggyogy Sz; 2007 Mar; 60(3-4):169-72. PubMed ID: 17451062
[TBL] [Abstract][Full Text] [Related]
36. Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.
Kamruecha W; Chansirikarnjana S; Nimkulrat E; Udommongkol C; Wongmek W; Thangnipon W
Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):793-7. PubMed ID: 17121308
[TBL] [Abstract][Full Text] [Related]
37. Gene co-expression networks identify Trem2 and Tyrobp as major hubs in human APOE expressing mice following traumatic brain injury.
Castranio EL; Mounier A; Wolfe CM; Nam KN; Fitz NF; Letronne F; Schug J; Koldamova R; Lefterov I
Neurobiol Dis; 2017 Sep; 105():1-14. PubMed ID: 28502803
[TBL] [Abstract][Full Text] [Related]
38. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
39. Dose- and ApoE isoform-dependent cognitive injury after cranial ⁵⁶Fe irradiation in female mice.
Villasana L; Dayger C; Raber J
Radiat Res; 2013 Apr; 179(4):493-500. PubMed ID: 23496055
[TBL] [Abstract][Full Text] [Related]
40. Androgens, apoE, and Alzheimer's disease.
Raber J
Sci Aging Knowledge Environ; 2004 Mar; 2004(11):re2. PubMed ID: 15028864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
